|
ATE67769T1
(de)
|
1983-01-25 |
1991-10-15 |
Ciba Geigy Ag |
Neue peptidderivate.
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
KR100310510B1
(ko)
|
1993-03-23 |
2002-07-04 |
장 스테판느 |
3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
|
|
WO2005009378A2
(en)
|
2003-07-24 |
2005-02-03 |
Merck & Co., Inc. |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
NZ544542A
(en)
|
2003-07-24 |
2009-01-31 |
Merck & Co Inc |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
CN1918176A
(zh)
|
2004-02-18 |
2007-02-21 |
默克公司 |
用于诱导针对金黄色葡萄球菌的保护性免疫反应的多肽
|
|
TWI382019B
(zh)
|
2005-08-19 |
2013-01-11 |
Array Biopharma Inc |
作為類鐸受體（ｔｏｌｌ-ｌｉｋｅ ｒｅｃｅｐｔｏｒ）調節劑之胺基二氮雜呯
|
|
TW200801003A
(en)
|
2005-09-16 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
|
WO2007034917A1
(ja)
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規なアデニン化合物
|
|
EP1939200A4
(en)
|
2005-09-22 |
2010-06-16 |
Dainippon Sumitomo Pharma Co |
NEW ADENINE CONNECTION
|
|
TW200745114A
(en)
|
2005-09-22 |
2007-12-16 |
Astrazeneca Ab |
Novel compounds
|
|
JPWO2007034881A1
(ja)
|
2005-09-22 |
2009-03-26 |
大日本住友製薬株式会社 |
新規アデニン化合物
|
|
EP1939202A4
(en)
|
2005-09-22 |
2010-06-16 |
Dainippon Sumitomo Pharma Co |
NEW ADENINE CONNECTION
|
|
AU2007216247A1
(en)
|
2006-02-17 |
2007-08-23 |
Pfizer Limited |
3 -deazapurine derivatives as TLR7 modulators
|
|
JP2009539979A
(ja)
|
2006-06-12 |
2009-11-19 |
ナビ バイオファーマシューティカルズ |
ブドウ球菌感染症を治療および予防するための、α毒素の使用
|
|
JP2009542645A
(ja)
|
2006-07-05 |
2009-12-03 |
アストラゼネカ・アクチエボラーグ |
Ｔｌｒ７のモジュレーターとして作用する８−オキソアデニン誘導体
|
|
US8338593B2
(en)
|
2006-07-07 |
2012-12-25 |
Gilead Sciences, Inc. |
Modulators of toll-like receptor 7
|
|
CA2667788A1
(en)
|
2006-10-30 |
2008-12-18 |
The University Of Western Ontario |
Staphylococcus aureus specific anti-infectives
|
|
JP2010519186A
(ja)
|
2007-02-19 |
2010-06-03 |
スミスクライン ビーチャム コーポレーション |
免疫調節物質としてのプリン誘導体
|
|
TW200902018A
(en)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound
|
|
BRPI0811125A2
(pt)
|
2007-05-08 |
2017-05-09 |
Astrazeneca Ab |
imidazoquinolinas com propriedades imunomoduladoras
|
|
ATE501136T1
(de)
|
2007-08-03 |
2011-03-15 |
Pfizer Ltd |
Imidazopyridinone
|
|
KR20100072228A
(ko)
|
2007-08-31 |
2010-06-30 |
유니버시티 오브 시카고 |
스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
|
|
PE20091236A1
(es)
|
2007-11-22 |
2009-09-16 |
Astrazeneca Ab |
Derivados de pirimidina como immunomoduladores de tlr7
|
|
SI2268618T1
(sl)
|
2008-03-03 |
2015-09-30 |
Novartis Ag |
Spojine in sestavki kot modulatorji aktivnosti TLR
|
|
KR101606219B1
(ko)
|
2008-03-24 |
2016-03-24 |
4에스체 악티엔게젤샤프트 |
신규 치환된 이미다조퀴놀린
|
|
CA2732437C
(en)
|
2008-08-01 |
2017-11-21 |
Ventirx Pharmaceuticals, Inc. |
Toll-like receptor agonist formulations and their use
|
|
UY32306A
(es)
|
2008-12-09 |
2010-07-30 |
Gilead Sciences Inc |
Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos
|
|
EP2419129A2
(en)
*
|
2009-04-14 |
2012-02-22 |
Novartis AG |
Compositions for immunising against staphylococcus aerus
|
|
AU2010264538B2
(en)
*
|
2009-06-22 |
2013-10-03 |
Wyeth Llc |
Immunogenic compositions of Staphylococcus aureus antigens
|
|
AU2010272505B2
(en)
|
2009-07-16 |
2015-09-17 |
Glaxosmithkline Biologicals S.A. |
Treatment of infections
|
|
GB0913680D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
GB0913681D0
(en)
*
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
JO3257B1
(ar)
|
2009-09-02 |
2018-09-16 |
Novartis Ag |
مركبات وتركيبات كمعدلات لفاعلية tlr
|
|
US9950062B2
(en)
|
2009-09-02 |
2018-04-24 |
Glaxosmithkline Biologicals Sa |
Compounds and compositions as TLR activity modulators
|
|
EA031379B1
(ru)
|
2010-03-23 |
2018-12-28 |
Новартис Аг |
Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
|
|
JP2013538217A
(ja)
|
2010-09-01 |
2013-10-10 |
ノバルティス アーゲー |
不溶性金属塩への免疫増強物質の吸着
|
|
CN103533954B
(zh)
*
|
2011-03-02 |
2015-09-09 |
诺华股份有限公司 |
含较低剂量的抗原和/或佐剂的联合疫苗
|
|
SG11201400210RA
(en)
*
|
2011-09-01 |
2014-03-28 |
Novartis Ag |
Adjuvanted formulations of staphylococcus aureus antigens
|
|
WO2013131983A1
(en)
*
|
2012-03-07 |
2013-09-12 |
Novartis Ag |
Adjuvanted formulations of streptococcus pneumoniae antigens
|
|
CA2866406A1
(en)
*
|
2012-03-08 |
2013-09-12 |
Novartis Ag |
Adjuvanted formulations of booster vaccines
|
|
EP2822584A1
(en)
*
|
2012-03-08 |
2015-01-14 |
Novartis AG |
Combination vaccines with tlr4 agonists
|
|
WO2014033191A1
(en)
*
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
Stabilised proteins for immunising against staphylococcus aureus
|
|
EP2890388A1
(en)
*
|
2012-08-31 |
2015-07-08 |
Novartis AG |
Stabilised proteins for immunising against staphylococcus aureus
|
|
EP2890387A1
(en)
*
|
2012-08-31 |
2015-07-08 |
Novartis AG |
Stabilised proteins for immunising against staphylococcus aureus
|
|
TR201910573T4
(tr)
*
|
2012-08-31 |
2019-08-21 |
Glaxosmithkline Biologicals Sa |
Staphylococcus aureus'a karşı bağışıklık kazandırmak için stabilize edilmiş proteinler.
|
|
BR112015005056A2
(pt)
*
|
2012-09-06 |
2017-11-21 |
Novartis Ag |
vacinas de combinação com sorogrupo b meningococcus e d/t/p
|
|
GB201219420D0
(en)
*
|
2012-10-29 |
2012-12-12 |
Novartis Ag |
Staphyloccal immunogens
|
|
US9827190B2
(en)
*
|
2013-02-01 |
2017-11-28 |
Glaxosmithkline Biologicals Sa |
Intradermal delivery of immunological compositions comprising toll-like receptor 7 agonists
|
|
WO2015140108A1
(en)
*
|
2014-03-17 |
2015-09-24 |
Gaxosmithkline Biologicals Sa |
Immunising against staphylococcal bone and joint infections
|
|
WO2015144691A1
(en)
*
|
2014-03-26 |
2015-10-01 |
Glaxosmithkline Biologicals Sa |
Compositions for immunising against staphylococcus aureus
|
|
MX377794B
(es)
*
|
2014-03-26 |
2025-03-10 |
Glaxosmithkline Biologicals Sa |
Antigenos estafilococicos mutantes.
|